2m 2m 2m 2m 2m 2m 2m
Annovis Bio (ANVS)
NYSE
$1.14+$0.01 (+1.34%)
Price as of Sep 11, 2026 7:43 PM EDT- $47.7MMarket Cap
- -54.84%1-Year Change
- BiotechnologyIndustry
Annovis Bio (ANVS)
$1.14+$0.01 (+1.34%)
ANVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.12 | ||
Change | -$0.07 (-5.88%) | ||
Open | $1.20 | ||
High | $1.23 | ||
Low | $1.10 | ||
Previous Close | $1.19 | ||
Volume | 1,894,431 | ||
30-Day Average Volume | 1,125,511 | ||
1-Week Change | -19.42% | ||
1-Month Change | -40.74% | ||
1-Year Change | -54.84% | ||
3-Year Change | -90.30% | ||
5-Year Change | -96.83% | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $22.0M | ||
Market Cap | $47.7M | ||
Enterprise Value | $29.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.8M | ||
Free Cash Flow | -$21.9M | ||
EBIT | -$14.8M | ||
EBITDA | -$14.8M | ||
Net Working Capital | $12.4M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -11 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue